Mumbai, India

Suhas M Nadkarni


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suhas M Nadkarni: A Pioneer in Anti-Inflammatory Compounds

Introduction

Suhas M Nadkarni is a notable inventor based in Mumbai, India, recognized for his significant contributions to the field of pharmaceutical chemistry. With a strong focus on developing innovative solutions to combat inflammation, he has made strides in anti-inflammatory research.

Latest Patents

Suhas M Nadkarni holds a patent for "Anti-inflammatory compounds - Biphenyl compounds of Formula (I) and Formula (II)". This patent encompasses various pharmaceutically acceptable salts, solvates, or prodrugs, associated pharmaceutical compositions, their applications, and the processes utilized in their preparation. The compounds detailed in this patent are uniquely designed to exhibit potent anti-inflammatory properties, showcasing Nadkarni's commitment to advancing healthcare solutions.

Career Highlights

Suhas currently works for Elder Pharmaceuticals Ltd., a prominent company in the pharmaceutical industry, where he contributes actively to innovative research and development projects. His work has had a significant impact on the company's capabilities and offerings in the pharmaceutical landscape.

Collaborations

Throughout his career, Suhas has collaborated with several talented professionals, including Rajiv R Sakhardande and Vithal Kulkarni. These collaborations are essential for fostering innovative ideas and refining the processes involved in the development of new pharmaceutical compounds, showcasing a team-oriented approach to scientific research.

Conclusion

Suhas M Nadkarni's contributions to the field of anti-inflammatory compounds exemplify the critical role inventors play in advancing healthcare. His innovative patent not only highlights his expertise but also lays the groundwork for further improvements in the treatment of inflammatory conditions. With ongoing collaborations and a commitment to research, Nadkarni continues to be a significant force in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…